Herbalife (NYSE:HLF) Upgraded by Zacks Research to “Strong-Buy” Rating

Zacks Research upgraded shares of Herbalife (NYSE:HLF) from a hold rating to a strong-buy rating in a research note published on Thursday,Zacks.com reports.

A number of other analysts also recently weighed in on the company. Citigroup restated a “buy” rating and issued a $21.00 price target (up from $17.00) on shares of Herbalife in a research note on Thursday. Weiss Ratings reissued a “hold (c)” rating on shares of Herbalife in a report on Thursday, January 22nd. Argus set a $15.00 price target on shares of Herbalife in a research note on Wednesday, November 26th. Mizuho set a $13.00 price target on shares of Herbalife and gave the company a “neutral” rating in a report on Thursday, January 8th. Finally, Maxim Group started coverage on shares of Herbalife in a report on Tuesday, January 6th. They set a “buy” rating and a $20.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $16.60.

Herbalife Stock Up 1.8%

Shares of NYSE:HLF opened at $19.92 on Thursday. The company has a market cap of $2.06 billion, a price-to-earnings ratio of 9.05 and a beta of 0.84. The firm’s 50-day simple moving average is $15.60 and its 200-day simple moving average is $11.72. Herbalife has a fifty-two week low of $6.20 and a fifty-two week high of $20.34.

Herbalife (NYSE:HLF) last posted its quarterly earnings results on Wednesday, February 18th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.48 by ($0.03). The firm had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Herbalife had a negative return on equity of 35.02% and a net margin of 4.53%.The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.36 earnings per share. On average, research analysts forecast that Herbalife will post 1.57 EPS for the current year.

Institutional Investors Weigh In On Herbalife

A number of large investors have recently added to or reduced their stakes in HLF. Mercer Global Advisors Inc. ADV acquired a new position in Herbalife during the fourth quarter worth about $152,000. Oxford Asset Management LLP purchased a new position in shares of Herbalife during the 4th quarter worth approximately $302,000. Invenomic Capital Management LP increased its stake in shares of Herbalife by 82.6% during the 4th quarter. Invenomic Capital Management LP now owns 768,031 shares of the company’s stock worth $9,900,000 after purchasing an additional 347,401 shares in the last quarter. Engineers Gate Manager LP acquired a new position in shares of Herbalife during the 4th quarter worth approximately $1,582,000. Finally, Boothbay Fund Management LLC lifted its stake in Herbalife by 414.5% in the 4th quarter. Boothbay Fund Management LLC now owns 64,187 shares of the company’s stock valued at $827,000 after buying an additional 51,711 shares in the last quarter.

Trending Headlines about Herbalife

Here are the key news stories impacting Herbalife this week:

• Positive Sentiment: Cristiano Ronaldo purchased a disclosed minority stake (reported as ~10% of the Pro2col unit), which investors have treated as a credibility and growth signal for Herbalife’s wellness/tech spinout. Cristiano Ronaldo Invests $7.5 Million Into Herbalife—Stock Surges
• Positive Sentiment: Q4 revenue (≈$1.28–1.30B) topped consensus and the company issued FY/quarter guidance in line with or slightly above Street expectations — supporting the view that top-line growth is intact. Herbalife (NYSE:HLF) Beats Q4 CY2025 Sales Expectations, Stock Jumps 11.7%
• Positive Sentiment: Analysts and quant-rank services turned more constructive: Maxim reiterated a Buy and Zacks added HLF to its Rank #1 (Strong Buy) lists, boosting short-term demand from retail and model-driven funds. Buy Rating on Herbalife Driven by Turnaround Momentum… New Strong Buy Stocks for February 20th
• Positive Sentiment: Shares hit a 52-week / multi-year high on the combined impact of the deal news, better-than-expected net sales and increased volume — momentum that can attract momentum/trend traders. Herbalife (HLF) Climbs to 3-Year High on Net Sales Beat
• Neutral Sentiment: The full Q4 earnings call transcript and slide deck are available for investors who want detailed color on product innovation, distributor trends and digital personalization initiatives — useful for modeling longer-term growth but not an immediate catalyst by itself. Herbalife Q4 2025 earnings call transcript
• Negative Sentiment: Mixed profitability signals: while revenue and operating cash flow grew, reported EPS metrics missed some consensus figures and the company showed year-over-year declines in operating profit and net income, which raises questions about margin recovery. Herbalife Ltd. (HLF) stock rises on Q4 2025 Earnings
• Negative Sentiment: Some outlets flagged an EPS miss versus consensus and a negative ROE / thin net margin — fundamentals investors watch for sustained valuation support. Herbalife Ltd (HLF) Misses Q4 Earnings and Revenue Estimates

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.